低中度近视眼内镜植入术与微小切口角膜基质透镜取出术对比:随机非劣效性试验研究方案
本研究为前瞻性随机非劣效性试验,计划纳入300例球镜当量小于-6.0D的低中度近视受试者,随机分为ICL/TICL组与SMILE组,术后随访至18个月,主要结局为各时间点术后球镜当量在目标值±0.5D和±1.0D以内的眼数比例,以评估ICL/TICL与SMILE的屈光结果是否相当。
要点
- 拟纳入300例球镜当量小于-6.0D的低中度近视受试者,随机分为ICL/TICL组与SMILE组。
- 主要结局为术后各时间点球镜当量在目标值±0.5D和±1.0D以内的眼数比例。
- 术后随访时间为1、3、6、12和18个月,评估屈光可预测性等指标。
核心结论
- 该试验将提供ICL与SMILE在低中度近视中屈光结果是否相当的信息,为临床转化提供证据。
研究设计与样本
- 前瞻性随机非劣效性试验,计划纳入300例球镜当量小于-6.0D的受试者,随机分为ICL/TICL组和SMILE组。
主要发现
- 主要结局为术后各时间点球镜当量在目标值±0.5D和±1.0D以内的眼数比例。
- 次要结局包括视力、屈光、不良事件和视觉质量测量。
- 术后随访时间为1、3、6、12和18个月。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implantable collamer lens implantation (ICL) is a form of 'foldable' posterior chamber phakic intraocular lens refractive surgery that generally does not impair cornea and natural accommodation. The potential advantages of the ICL over keratorefractive laser procedures include less induction of higher-order aberrations (HOAs) and enhanced retinal image magnification. On the other hand, small incision lenticule extraction (SMILE), currently, one of the most popular refractive surgery procedures, also offers excellent visual outcomes, particularly for eyes with low to moderate amounts of myopia. The aim of this study is to evaluate whether ICL/TICL (toric ICL) is comparable to SMILE for low to moderate myopia in terms of refractive outcomes at 3 and 18 months post-operatively. METHODS/DESIGN: This is a prospective randomized study. A total of 300 participants will be randomized into two groups, the ICL/TICL group and SMILE group. Eligible participants with spherical equivalent (SE) less than - 6.0 diopter (D) will be recruited. Following randomization, participants will be followed at 1, 3, 6, 12, and 18 months. The primary outcome is the refractive predictability at every postoperative point after surgery, which is the proportion of the number of eyes achieving a postoperative SE within ± 0.5 D and ± 1.0 D of the intended target. Secondary outcome parameters include visual acuity, refraction, adverse events, and quality of vision measurements. DISCUSSION: This trial will provide information on whether ICL has comparable, if not superior, refractive outcomes compared to the established SMILE for low to moderate myopia, thus providing evidence for translation into clinical practice. TRIAL REGISTRATION: Chinese clinical trial registry (ChiCTR) 2200055372. Registered on 08 January 2022.
引用
- Li K, Wang Z, Wang MX, et al. Implantable collamer lens implantation (ICL) versus small incision lenticule extraction (SMILE) in low to moderate myopia: study protocol for a randomized, non-inferiority trial. Trials. 2022. PMID: 36307873. doi:10.1186/s13063-022-06851-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。